Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients

NCT02629965 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: tiotropium
DRUG: olodaterol
DRUG: tiotropium

Sponsor

Boehringer Ingelheim